UniProtKB/Swiss-Prot Q5T4W7: Variant p.Gln19Arg

Artemin
Gene: ARTN
Feedback?

Variant information Variant position:

19 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamine (Q) to Arginine (R) at position 19 (Q19R, p.Gln19Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (Q) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs2242637 [ dbSNP | Ensembl ]

Sequence information Variant position:

19 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

220 The length of the canonical sequence.
Location on the sequence:

MELGLGGLSTLSHCPWPR Q QPALWPTLAALALLSSVAEA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MELGLGGLSTLSHCPWPRQQPALWPTLAALALLSSVAEA

Mouse                         MELGLAEPTALSHCLRPRWQSAWWPTLAVLALLSCVTEA

Rat                           MELGLGEPTALSHCLRPRWQPALWPTLAALALLSSVTEA

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Signal peptide	1 – 39
Alternative sequence	1 – 19	MELGLGGLSTLSHCPWPRQ -> MPGLISARGQPLLEVLPPQAHLGALFLPEAPLGLSA. In isoform 2.
Alternative sequence	21 – 21	P -> APLGLSAQP. In isoform 3.

Literature citations
Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex.
Baloh R.H.; Tansey M.G.; Lampe P.A.; Fahrner T.J.; Enomoto H.; Simburger K.S.; Leitner M.L.; Araki T.; Johnson E.M. Jr.; Milbrandt J.;
Neuron 21:1291-1302(1998)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2); FUNCTION; TISSUE SPECIFICITY; DEVELOPMENTAL STAGE; VARIANT ARG-19; Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variants.
Masure S.; Geerts H.; Cik M.; Hoefnagel E.; Van Den Kieboom G.; Tuytelaars A.; Harris S.; Lesage A.S.J.; Leysen J.E.; van der Helm L.; Verhasselt P.; Yon J.; Gordon R.D.;
Eur. J. Biochem. 266:892-902(1999)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 3); FUNCTION; TISSUE SPECIFICITY; VARIANT ARG-19; In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin.
Rosenblad C.; Gronborg M.; Hansen C.; Blom N.; Meyer M.; Johansen J.; Dago L.; Kirik D.; Patel U.A.; Lundberg C.; Trono D.; Bjoerklund A.; Johansen T.E.;
Mol. Cell. Neurosci. 15:199-214(2000)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT ARG-19;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.